2011Yanwaishang zhiye yanbing zazhiRequires access

Influence of mitomycin C in artificial nasolacrimal stent placement to treat chronic dacryocystitis

Yin-juan Shi, Zhulin Hu

Open publisher page 0 citations

Abstract

Objective To explore the influence of Mitomycin C(MMC)in artificial nasolacrimal stent placement to treat chronic dacryocystitis.Methods 89 cases(98 eyes)of chronic dacryocystitis were divided into Mitomycin C group and control group.In the former,0.5 mL of MMC(0.02%)Was injected into the lacrimal duct during the operation and postoperation,and the latter with no MMC.Results All cases were followed-up for 10~12 months in the postopemtion.Lacrimal drainage systems were patent in 35/36 eyes in MMC group,and 53/62 eyes in control group.There Was a statistically significant difference between MMC group and control group(P=0.004,Fisher's Exact Test).Conclusion MMC in artificial nasolacrimal stent placement postoperafively seems a safe and effective adjuvant procedure and can maintain higher long-term Success rate. Key words: Mitomycin C; Nasolacrimal duct; Artificial; Implatation

About this research paper

What this paper is about

Objective To explore the influence of Mitomycin C(MMC)in artificial nasolacrimal stent placement to treat chronic dacryocystitis.Methods 89 cases(98 eyes)of chronic dacryocystitis were divided into Mitomycin C group and control group.In the former,0.5 mL of MMC(0.02%)Was injected into the lacrimal duct during the operation and postoperation,and the latter with no MMC.Results All cases were followed-up for 10~12 months in the postopemtion.Lacrimal drainage systems were patent in 35/36 eyes in MMC group,and 53/62 eyes in control group.There Was a statistically significant difference between MMC group and control group(P=0.004,Fisher's Exact Test).Conclusion MMC in artificial nasolacrimal stent placement postoperafively seems a safe and effective adjuvant procedure and can maintain higher long-term Success rate. Key words: Mitomycin C; Nasolacrimal duct; Artificial; Implatation

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the influence of Mitomycin C(MMC)in artificial nasolacrimal stent placement to treat chronic dacryocystitis.Methods 89 cases(98 eyes)of chronic dacryocystitis were divided into Mitomycin C group and control group.In the former,0.5 mL of MMC(0.02%)Was injected into the lacrimal duct during the operation and postoperation,and the latter with no MMC.Results All cases were followed-up for 10~12 months in the postopemtion.Lacrimal drainage systems were patent in 35/36 eyes in MMC group,and 53/62 eyes in control group.There Was a statistically significant difference between MMC group and control group(P=0.004,Fisher's Exact Test).Conclusion MMC in artificial nasolacrimal stent placement postoperafively seems a safe and effective adjuvant procedure and can maintain higher long-term Success rate. Key words: Mitomycin C; Nasolacrimal duct; Artificial; Implatation

Key concepts: Medicine, Chronic dacryocystitis, Mitomycin C, Nasolacrimal duct, Stent, Surgery, Dacryocystitis, Canthus

Related papers

Back to paper searchBrowse research topicsOriginal source
Influence of mitomycin C in artificial nasolacrimal stent placement to treat chronic dacryocystitis — Research Paper | ScholarLens